| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447503 | European Journal of Cancer | 2011 | 6 Pages |
Abstract
Weekly docetaxel combined with irinotecan has acceptable safety and modest efficacy in the second-line treatment of advanced oesophagogastric cancer. Further prospective evaluation of this regimen is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eliza Hawkes, Alicia F.C. Okines, Demetris Papamichael, Sheela Rao, Sue Ashley, Haris Charalambous, Alona Koukouma, Ian Chau, David Cunningham,